Beacon Therapeutics
Alachua
About Beacon Therapeutics
Beacon Therapeutics is a biotechnology firm in the clinical stage focused on preserving and enhancing vision for individuals affected by both uncommon and widespread eye disorders. The organization is leveraging the revolutionary potential of gene therapy to achieve significant results for serious eye conditions. Currently, Beacon's pipeline is aimed at severe retinal diseases that cause blindness, including X-linked retinitis pigmentosa (XLRP) and geographic atrophy.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Total funding: $365.1M
- Funding stage: Late Stage Venture
- Last round: Series C (Jan 2026)
- Website: beacontx.com
- Phone: +1 386 462 2204
Industries & Categories
Biotechnology, Health Care, Life Science, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/beacon-therapeutics-3560 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.